Quick Summary
- DKNG shares declined approximately 10% on Wednesday, reaching $22.52 with unusually light volume—82% below typical trading levels
- Senate betting legislation spooked investors, sparking a significant sell-off in the sports betting stock
- NCAA initiated legal proceedings against DraftKings targeting the company’s use of “March Madness” branding during the tournament’s busiest betting period
- The company reduced its 2026 revenue projections to $6.5–6.9B earlier this year, falling more than $600M short of analyst expectations
- Wall Street maintains a “Moderate Buy” rating with average analyst targets at $37.09, representing significant upside from current trading levels
DraftKings (DKNG) shares settled near $22.52 during Wednesday’s session, reflecting a roughly 10% decline.
The Wednesday decline resulted from dual challenges facing the sports betting giant. Market participants reacted negatively to developments surrounding Senate betting legislation, while simultaneously the NCAA launched legal action attempting to prevent the company from utilizing tournament-specific branding including “March Madness.”
The NCAA’s legal filing arrives at an especially challenging moment. The lawsuit emerged during the height of college basketball’s premier tournament—representing one of the most profitable windows for sports wagering platforms. Marketing restrictions or potential injunctions could hamper promotional campaigns and affect near-term revenues.
Trading activity on Wednesday totaled just over 2.8 million shares, approximately 82% lighter than the standard session volume of 15.6 million. Such reduced liquidity can exaggerate price movements on both the upside and downside.
The current challenges add to an already difficult 2026 for DKNG. Management previously issued full-year revenue guidance of $6.5–6.9 billion, disappointing analysts who had projected figures more than $600 million higher. Shares experienced a mid-teens percentage drop following that announcement and have faced continued headwinds.
Revenue Outlook Disappoints Following Stellar 2025 Performance
The guidance reduction proved particularly jarring considering the strength of Q4 2025 results. Revenue reached approximately $1.99 billion, marking 43% growth year-over-year. Full-year adjusted EBITDA surged beyond $620 million—more than tripling prior results—while the company achieved its inaugural year of positive net income.
DraftKings accomplished key profitability milestones investors had anticipated—then tempered future expectations. This dynamic recalibrated the company’s growth trajectory entering 2026.
Shares currently trade below both the 50-day moving average at $26.39 and the 200-day moving average at $32.01, illustrating ongoing pressure following the guidance revision.
Regarding competitive positioning, DraftKings has pursued aggressive pricing strategies. Analysis conducted during the March Madness tournament identified DKNG as offering the tightest average vig among leading sportsbook operators on money-line and total wagers. This approach maintains customer engagement while creating margin compression.
Analyst Community Maintains Optimism Despite Target Adjustments
The analyst community continues supporting the stock. Twenty-five analysts assign Buy ratings, five recommend Hold positions, and two suggest Sell. The consensus 12-month price objective stands at $37.09—representing more than 60% potential appreciation from Wednesday’s closing level.
Mizuho reduced its price target from $46 to $44 while preserving an “outperform” designation. Stifel lowered its forecast from $44 to $40, retaining a “buy” recommendation. Jefferies maintains a $46 objective. Wells Fargo reaffirmed an “overweight” stance.
Regarding insider activity, Director Harry Sloan acquired 100,000 shares at $21.85 during February—representing a $2.185 million investment signaling confidence at those price levels. That transaction now trades approximately flat with current market prices.
Insiders collectively have divested roughly 549,495 shares during the previous 90 days, while maintaining 47.08% ownership of the company. Institutional investors hold 37.7% of outstanding shares.
The stock trades near its 52-week low range, with market capitalization around $10.63 billion and a beta coefficient of 1.67.
